PLT Test Blog

    Today’s post is about some drugs/supplements that have already been discussed in earlier posts.   Rifaximin, used in cycles, is an effective part of our reader Maja’s therapy, while Sodium Butyrate was highlighted long ago by our reader in Switzerland, Alli. I had a consultation with a gastroenterologist last week and came away with a prescription for Rifaximin, microencapsulated  Sodium Butyrate and Lactobacillus Plantarum 299v. Where we live, these are all inexpensive. Rifaximin is an antibiotic with extra benefits and costs about 7 euros (9 dollars).   A course of Rifaximin can cost $2,000 in the United States. I was pleased to read that the private equity owners of a pharmaceutical company that raised the price of a common thyroid drug by 6000% have just been fined $140 million in the UK. Advanz Pharma and former private equity owners were fined £100m by markets watchdog Perhaps some of our US readers should query the crazy price of drugs in the US...

There are many comorbidities associated with autism.   I have long held the view that these comorbidities hold the key to understanding each particular case of autism.   In many cases this may be far more useful than genetic testing, which only seems to help in a minority of cases. “Ringed esophagus” aka “Corrugated esophagus” This then allows you to put people into sub-groups that may well respond to the same therapy.   This may all sound like common sense, but apparently is not. Eosinophilic esophagitis (EoE) is a relatively new diagnosis and it is applies to a certain type of reflux/GERD/GORD that might be associated with a difficulty in swallowing and may not respond well to the standard stomach acid lowering therapies. It is likely that most people with Eosinophilic esophagitis have never been correctly diagnosed. Many people have taken several years to get the correct diagnosis. It is known that Eosinophilic esophagitis is much more common in autism than the genera...